{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:12:59Z","timestamp":1771845179467,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH119"],"award-info":[{"award-number":["ZR2021MH119"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH158"],"award-info":[{"award-number":["ZR2021MH158"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10549-026-07911-x","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:43:40Z","timestamp":1770363820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TMEM205 promotes M2-like macrophage polarization and advances the progression of triple-negative breast cancer"],"prefix":"10.1007","volume":"216","author":[{"given":"Yining","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"7911_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"7911_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L (2022) Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol 19:91\u2013113. https:\/\/doi.org\/10.1038\/s41571-021-00565-2","journal-title":"Nat Rev Clin Oncol"},{"key":"7911_CR3","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","volume":"379","author":"P Schmid","year":"2018","unstructured":"Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Di\u00e9ras V, Hegg R, Im SA, Shaw Wright G et al (2018) Atezolizumab and Nab-Paclitaxel in advanced triple-negative breast cancer. N Engl J Med 379:2108\u20132121. https:\/\/doi.org\/10.1056\/NEJMoa1809615","journal-title":"N Engl J Med"},{"key":"7911_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19:369\u2013382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6","journal-title":"Nat Rev Immunol"},{"key":"7911_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s10120-024-01517-2","volume":"27","author":"Q Fu","year":"2024","unstructured":"Fu Q, Wu X, Lu Z, Chang Y, Jin Q, Jin T, Zhang M (2024) TMEM205 induces TAM\/M2 polarization to promote cisplatin resistance in gastric cancer. Gastric Cancer 27:998\u20131015. https:\/\/doi.org\/10.1007\/s10120-024-01517-2","journal-title":"Gastric Cancer"},{"key":"7911_CR6","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M (2015) The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn) 19:A68-77. https:\/\/doi.org\/10.5114\/wo.2014.47136","journal-title":"Contemp Oncol (Pozn)"},{"key":"7911_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19:649\u2013658. https:\/\/doi.org\/10.1016\/j.neo.2017.05.002","journal-title":"Neoplasia"},{"key":"7911_CR8","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS (2020) Timer2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509-w514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Res"},{"key":"7911_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.575776","volume":"11","author":"J Rao","year":"2020","unstructured":"Rao J, Wu X, Zhou X, Deng R, Ma Y (2020) TMEM205 is an independent prognostic factor and is associated with immune cell infiltrates in hepatocellular carcinoma. Front Genet 11:575776. https:\/\/doi.org\/10.3389\/fgene.2020.575776","journal-title":"Front Genet"},{"key":"7911_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"7911_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18:220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1","journal-title":"Genome Biol"},{"key":"7911_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"7911_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70010","volume":"38","author":"X Jin","year":"2024","unstructured":"Jin X, Fu C, Chen Y, Jin C, Jin G, Yan J (2024) WNT1\/ROR2 pathway enhances the triple-negative breast cancer invasion, migration, and epithelial-mesenchymal transition. J Biochem Mol Toxicol 38:e70010. https:\/\/doi.org\/10.1002\/jbt.70010","journal-title":"J Biochem Mol Toxicol"},{"key":"7911_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) EMT: 2016. Cell 166:21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"key":"7911_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36:1461\u20131473. https:\/\/doi.org\/10.1038\/onc.2016.304","journal-title":"Oncogene"},{"key":"7911_CR16","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1080\/21655979.2021.1960464","volume":"12","author":"B Yang","year":"2021","unstructured":"Yang B, Wang F, Zheng G (2021) Transmembrane protein TMEM119 facilitates the stemness of breast cancer cells by activating Wnt\/\u03b2-catenin pathway. Bioengineered 12:4856\u20134867. https:\/\/doi.org\/10.1080\/21655979.2021.1960464","journal-title":"Bioengineered"},{"key":"7911_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298\u2013307. https:\/\/doi.org\/10.1038\/nature10144","journal-title":"Nature"},{"key":"7911_CR18","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.gendis.2022.07.006","volume":"10","author":"J Liu","year":"2023","unstructured":"Liu J, Shi Y, Wu M, Zhang F, Xu M, He Z, Tang M (2023) JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1. Genes Dis 10:2167\u20132178. https:\/\/doi.org\/10.1016\/j.gendis.2022.07.006","journal-title":"Genes Dis"},{"key":"7911_CR19","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1002\/jcp.27641","volume":"234","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zheng Q, He G, Zhang M, Yan X, Yang Z, Zhang P, Wang L, Liu J, Liang L et al (2019) Transmembrane protein 215 promotes angiogenesis by maintaining endothelial cell survival. J Cell Physiol 234:9525\u20139534. https:\/\/doi.org\/10.1002\/jcp.27641","journal-title":"J Cell Physiol"},{"key":"7911_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T et al (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14\u201320. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.008","journal-title":"Immunity"},{"key":"7911_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1111\/cas.16200","volume":"115","author":"Y Dai","year":"2024","unstructured":"Dai Y, Ji Z, Liang H, Jiang M, Wang L, Bao X, Liu J, Liu M, Yang C (2024) CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R\/STAT3 axis. Cancer Sci 115:2235\u20132253. https:\/\/doi.org\/10.1111\/cas.16200","journal-title":"Cancer Sci"},{"key":"7911_CR22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s00262-017-2052-5","volume":"66","author":"XL Fu","year":"2017","unstructured":"Fu XL, Duan W, Su CY, Mao FY, Lv YP, Teng YS, Yu PW, Zhuang Y, Zhao YL (2017) Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunol Immunother 66:1597\u20131608. https:\/\/doi.org\/10.1007\/s00262-017-2052-5","journal-title":"Cancer Immunol Immunother"},{"key":"7911_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R (2014) Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14:736\u2013746. https:\/\/doi.org\/10.1038\/nrc3818","journal-title":"Nat Rev Cancer"},{"key":"7911_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O'Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368:161\u2013170. https:\/\/doi.org\/10.1056\/NEJMra1202117","journal-title":"N Engl J Med"},{"key":"7911_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.703431","volume":"15","author":"C Cocola","year":"2021","unstructured":"Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E et al (2021) Transmembrane protein TMEM230, a target of glioblastoma therapy. Front Cell Neurosci 15:703431. https:\/\/doi.org\/10.3389\/fncel.2021.703431","journal-title":"Front Cell Neurosci"},{"key":"7911_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jcp.22287","volume":"225","author":"DW Shen","year":"2010","unstructured":"Shen DW, Ma J, Okabe M, Zhang G, Xia D, Gottesman MM (2010) Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. J Cell Physiol 225:822\u2013828. https:\/\/doi.org\/10.1002\/jcp.22287","journal-title":"J Cell Physiol"},{"key":"7911_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ygyno.2021.10.076","volume":"164","author":"CA Calo","year":"2022","unstructured":"Calo CA, Smith BQ, Dorayappan KDP, Saini U, Lightfoot M, Wagner V, Kalaiyarasan D, Cosgrove C, Wang QE, Maxwell GL et al (2022) Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: an implication for the antitumor potential of DAP compound. Gynecol Oncol 164:136\u2013145. https:\/\/doi.org\/10.1016\/j.ygyno.2021.10.076","journal-title":"Gynecol Oncol"},{"key":"7911_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01345","volume":"9","author":"K Schmit","year":"2018","unstructured":"Schmit K, Michiels C (2018) TMEM proteins in cancer: a review. Front Pharmacol 9:1345. https:\/\/doi.org\/10.3389\/fphar.2018.01345","journal-title":"Front Pharmacol"},{"key":"7911_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11095-011-0562-y","volume":"29","author":"DW Shen","year":"2012","unstructured":"Shen DW, Gottesman MM (2012) RAB8 enhances TMEM205-mediated cisplatin resistance. Pharm Res 29:643\u2013650. https:\/\/doi.org\/10.1007\/s11095-011-0562-y","journal-title":"Pharm Res"},{"key":"7911_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437. https:\/\/doi.org\/10.1038\/nm.3394","journal-title":"Nat Med"},{"key":"7911_CR31","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1038\/s41388-018-0160-0","volume":"37","author":"H Itoh","year":"2018","unstructured":"Itoh H, Kadomatsu T, Tanoue H, Yugami M, Miyata K, Endo M, Morinaga J, Kobayashi E, Miyamoto T, Kurahashi R et al (2018) TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma. Oncogene 37:2903\u20132920. https:\/\/doi.org\/10.1038\/s41388-018-0160-0","journal-title":"Oncogene"},{"key":"7911_CR32","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1038\/s41388-024-03182-2","volume":"43","author":"T Sakaue","year":"2024","unstructured":"Sakaue T, Dorayappan KDP, Zingarelli R, Khadraoui W, Anbalagan M, Wallbillich J, Bognar B, Wanner R, Cosgrove C, Suarez A et al (2024) Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and metformin. Oncogene 43:3586\u20133597. https:\/\/doi.org\/10.1038\/s41388-024-03182-2","journal-title":"Oncogene"},{"key":"7911_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0934-9","volume":"37","author":"T Qin","year":"2018","unstructured":"Qin T, Li B, Feng X, Fan S, Liu L, Liu D, Mao J, Lu Y, Yang J, Yu X et al (2018) Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity. J Exp Clin Cancer Res 37:287. https:\/\/doi.org\/10.1186\/s13046-018-0934-9","journal-title":"J Exp Clin Cancer Res"},{"key":"7911_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N (2025) Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther 10:227. https:\/\/doi.org\/10.1038\/s41392-025-02280-1","journal-title":"Signal Transduct Target Ther"},{"key":"7911_CR35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.Cd-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, M\u00e6landsmo GM et al (2014) Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4:998\u20131013. https:\/\/doi.org\/10.1158\/2159-8290.Cd-14-0001","journal-title":"Cancer Discov"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07911-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-07911-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-07911-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:50:50Z","timestamp":1771843850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-07911-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7911"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-07911-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal study was reviewed and approved by the Animal Ethics Committee of the Affiliated Hospital of Qingdao University (Approval No. AHQU-MAL). All procedures were performed in accordance with the national guidelines for the care and use of laboratory animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1"}}